Medifast (MED) Tops Q4 EPS by 1c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $11.77 -1.59%
Revenue Growth %: -24.3%
Financial Fact:
Selling, general, and administration: 43.21M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -24.3%
Financial Fact:
Selling, general, and administration: 43.21M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $0.34, $0.01 better than the analyst estimate of $0.33. Revenue for the quarter came in at $62.5 million versus the consensus estimate of $65.01 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Anthropic delays planned IPO from October to November - WSJ
- Barclays says AI trade is maturing, favors greater diversification
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
